Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC
Clinical trial NCT03263767 · TERMINATED
Trial details
- NCT number
- NCT03263767
- Sponsor
- Nantes University Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-15
- Primary completion
- 2021-10-21
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.